Desloratadine NDC 71335-1000

NDC codes

FDA NDC Directory

Product NDC (as listed)71335-1000Labeler and product segments. Claims need a package NDC.

Product NDC at billing width71335-1000Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
71335-1000-1	71335100001	30 TABLET, FILM COATED in 1 BOTTLE (71335-1000-1)Marketed from Nov 13, 2018
71335-1000-2	71335100002	90 TABLET, FILM COATED in 1 BOTTLE (71335-1000-2)Marketed from Apr 9, 2024
71335-1000-3	71335100003	60 TABLET, FILM COATED in 1 BOTTLE (71335-1000-3)Marketed from Apr 9, 2024

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Desloratadine
Generic name (nonproprietary): desloratadine
Active ingredients: Desloratadine — 5 mg/1
Dosage form: Tablet, Film coated
Route: Oral
Labeler: Bryant Ranch Prepack
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 078352
Marketing start: Feb 25, 2013
Listing expires: Dec 31, 2027
Other FDA classes: Histamine H1 Receptor Antagonists (Mechanism)
Identifiers: Product ID 71335-1000_b62a5a2c-ad72-4010-a6b7-b0f2593011c5SPL ID b62a5a2c-ad72-4010-a6b7-b0f2593011c5SPL set ID f84c8de3-a7d3-4e8b-bfb6-04259e79450aRxCUI 349420UNII FVF865388R
Pharmacologic class: Histamine-1 Receptor Antagonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N471335100001 followed by a unit qualifier and the quantity

Package 71335-1000-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jun 1, 2026.

Indications (excerpt from the label)

Desloratadine tablets are histamine-1 (H1) receptor antagonist indicated for: Seasonal Allergic Rhinitis: relief of nasal and non-nasal symptoms in patients 12 years of age and older. ( 1.1 ) Perennial Allergic Rhinitis: relief of nasal and non-nasal symptoms in patients 12 years of age and older. ( 1.2 ) 1.1 Seasonal Allergic Rhinitis Desloratadine tablets are indicated for the relief of the nasal and non-nasal symptoms of seasonal allergic rhinitis in patients 12 years of age and older. 1.2 Perennial Allergic Rhinitis Desloratadine tablets are indicated for the relief of the nasal and non-nasal symptoms of perennial allergic rhinitis in patients 12 years of age and older.…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 078352

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 078352
Product	Strength	Form · route	Labeler	Product NDC
Desloratadine	Desloratadine 5 mg/1	Tablet, Film coatedOral	A-S Medication Solutions	50090-6724
Desloratadine	Desloratadine 5 mg/1	Tablet, Film coatedOral	Lupin Pharmaceuticals, Inc.	68180-153
Desloratadine	Desloratadine 5 mg/1	Tablet, Film coatedOral	A-S Medication Solutions	50090-4794